Cogentis Therapeutics, Inc.

  • Home
  • Cogentis Therapeutics, Inc.

Cogentis Therapeutics, Inc. We are an early stage start-up with a mission to develop and commercialize innovative disease-modifying therapeutics for FTD and other Tauopathies.

We’re excited to announce that Cogentis Therapeutics was accepted into the 2020 MassChallenge Boston accelerator, where ...
18/06/2020

We’re excited to announce that Cogentis Therapeutics was accepted into the 2020 MassChallenge Boston accelerator, where we’ll have access to top industry experts, corporates, programming, and up to $1M in cash prizes.

JUNE 2, 2020 (BOSTON, MA) - MassChallenge, a global network of zero-equity startup accelerators, today announced the...

Facing formidable competition, Cogentis Therapeutics, Inc. just returned from Cambridge at the MIT-China Innovation and ...
22/11/2017

Facing formidable competition, Cogentis Therapeutics, Inc. just returned from Cambridge at the MIT-China Innovation and Entrepreneurship Forum (MIT-CHIEF) Business Plan Contest as overall winners with a Grand Prize of $30k. We won 1st of 8 finalists chosen from >200 start-ups. We pitched at MIT to a panel of judges with wide tech venture expertise including some of the world's foremost Chinese and Boston-affiliated investment firms. The prize money and new connections made at MIT-CHIEF will help to accelerate our vision of bringing a cure to patients and families suffering from Alzheimer’s and other neurodegenerative diseases.

Special thanks to Tian Xia and his team at MIT-CHIEF for organizing a brilliant weekend with top-notch speakers. Also thanks to the judges and sponsors such as Peter Miller, Charles Hsu, Hua Zhang, and MassChallenge for making it possible. And finally thanks to our mentors/advisors/supporters including Bruce Morimoto, Sanjeev Thohan, Li-Huei Tsai, Rosemarie Truman, Yvonne Angell, Chris Adams, Cydan Development, Inc., Dione T. Kobayashi, Barbara Slusher, Solomon Snyder, Ajay Verma, Stephen Haggarty.

18/07/2017

We’ve got our eyes on the $1M prize! Cogentis is moving on to the semifinals of , the $5M startup competition!

Help support our work and vision to end neurodegenerative disorders like Alzheimer's today by donating! https://www.amer...
06/05/2017

Help support our work and vision to end neurodegenerative disorders like Alzheimer's today by donating! https://www.americanbrainfoundation.org/projects/a-new-approach-to-treating-dementia/

Alzheimer’s disease and other neurodegenerative disorders including Frontotemporal dementia (FTD), Dementia with Lewy bodies(DLB), Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and progressive supranuclear palsy (PSP) are some of the most devastating afflictions faced by individuals, the...

Cogentis is named one of the Top 26 MassChallenge Finalists! http://t.co/uBf5XeShhz
14/10/2015

Cogentis is named one of the Top 26 MassChallenge Finalists! http://t.co/uBf5XeShhz

MassChallenge revealed on Wednesday morning the top 26 startups of its 2015 class that will move onto the final round of judging for a chance to share about $1.5 million in awards. The startups...

CoTx at One Start San Fran Gala!
14/06/2015

CoTx at One Start San Fran Gala!

Address


Alerts

Be the first to know and let us send you an email when Cogentis Therapeutics, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your business to be the top-listed Engineering Company?

Share